Format

Send to

Choose Destination
Transl Androl Urol. 2015 Jun;4(3):381-90. doi: 10.3978/j.issn.2223-4683.2015.06.02.

Advances in the treatment of testicular cancer.

Author information

1
1 Department of Urology, Rabin Medical Centre Beilinson Campus, Petah Tiqwa, Israel ; 2 Sackler Medical School, Tel Aviv University, P.O. Box 39040, Tel Aviv 69978, Israel.

Abstract

Germ cell tumors (GCT) are relatively uncommon, accounting for only 1% of male malignancies in the United States. It has become an important oncological disease for several reasons. It is the most common malignancy in young men 15-35 years old. GCTs are among a unique numbers of neoplasms where biochemical markers play a critical role. Finally, it is a model of curable cancer. In this review we discuss cancer epidemiology, genetics, and therapeutic principles. Recent advances in the management of stage I GCT and controversies in the management of post chemotherapy residual mass are presented.

KEYWORDS:

Neoplasms germ cell tumor; chemotherapy; chemotherapy adjuvant; incidence; lymph node excision; neoplasm staging; orchiectomy; patient selection; treatment outcome

Supplemental Content

Full text links

Icon for AME Publishing Company Icon for PubMed Central
Loading ...
Support Center